These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22701571)

  • 1. Allocating HIV prevention funds in the United States: recommendations from an optimization model.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    PLoS One; 2012; 7(6):e37545. PubMed ID: 22701571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for allocating CDC's HIV prevention resources in the United States.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal allocation of HIV prevention funds for state health departments.
    Yaylali E; Farnham PG; Cohen S; Purcell DW; Hauck H; Sansom SL
    PLoS One; 2018; 13(5):e0197421. PubMed ID: 29768489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal investment in a portfolio of HIV prevention programs.
    Zaric GS; Brandeau ML
    Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Theory to Practice: Implementation of a Resource Allocation Model in Health Departments.
    Yaylali E; Farnham PG; Schneider KL; Landers SJ; Kouzouian O; Lasry A; Purcell DW; Green TA; Sansom SL
    J Public Health Manag Pract; 2016; 22(6):567-75. PubMed ID: 26352385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Employing resource allocation modeling to inform HIV prevention planning for the state of Iowa.
    Holtgrave DR; Young PA; Mayer RR; Maulsby C; Kim JJ
    AIDS Educ Prev; 2013 Oct; 25(5):423-9. PubMed ID: 24059879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care policy. U.S. priorities-HIV prevention.
    Catania JA; Morin SF; Canchola J; Pollack L; Chang J; Coates TJ
    Science; 2000 Oct; 290(5492):717. PubMed ID: 11184201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allocating HIV prevention resources: a tool for state and local decision making.
    Richter A; Hicks KA; Earnshaw SR; Honeycutt AA
    Health Policy; 2008 Sep; 87(3):342-9. PubMed ID: 18342388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing HIV in injection drug users: choosing the best mix of interventions for the population.
    Wilson AR; Kahn JG
    J Urban Health; 2003 Sep; 80(3):465-81. PubMed ID: 12930884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.
    Shrestha RK; Sansom SL; Farnham PG
    J Public Health Manag Pract; 2012; 18(3):259-67. PubMed ID: 22473119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of federal HIV prevention spending on HIV testing and awareness.
    Linas BP; Zheng H; Losina E; Walensky RP; Freedberg KA
    Am J Public Health; 2006 Jun; 96(6):1038-43. PubMed ID: 16670217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A little planning goes a long way: multilevel allocation of HIV prevention resources.
    Zaric GS; Brandeau ML
    Med Decis Making; 2007; 27(1):71-81. PubMed ID: 17237455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
    Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
    J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV prevention community planning and communities of color: do resources track the epidemic?
    Holtgrave DR; Thomas CW; Chen H; Edlavitch S; Pinkerton SD; Fleming P
    AIDS Public Policy J; 2000; 15(2):75-81. PubMed ID: 11519369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-making in HIV prevention community planning: an integrative review.
    Johnson-Masotti AP; Pinkerton SD; Holtgrave DR; Valdiserri RO; Willingham M
    J Community Health; 2000 Apr; 25(2):95-112. PubMed ID: 10794204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Immunodeficiency Virus Testing, Diagnosis, Linkage to Care, and Prevention Services Among Persons Who Inject Drugs, United States, 2012-2017.
    Rao S; Song W; Mulatu MS; Seena E; Essuon A; Heitgerd J
    J Infect Dis; 2020 Sep; 222(Suppl 5):S268-S277. PubMed ID: 32877556
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.